Loomis, Sayles & Company
ASTH icon

Loomis, Sayles & Company’s Astrana Health ASTH Stock Holding History

Loomis, Sayles & Company’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-319,666
Closed -$10.1M – 764
2024
Q4 		$10.1M Sell
319,666
-202,443
-39% -$9.62M 0.01% 368
2024
Q3 		$30.3M Buy
+522,109
New +$25.7M 0.04% 198

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company's ASTH Position: Q1 2025 in Review

Loomis, Sayles & Company sold out of Astrana Health (ASTH) in Q1 2025, closing a stake of 319,666 shares — an estimated $10.1M sold.

Loomis, Sayles & Company first reported a position in ASTH in Q3 2024 and held it in 2 quarters. The position peaked at $30.3M in Q3 2024. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • Loomis, Sayles & Company reported no remaining Astrana Health position as of Q1 2025 after selling out during the quarter.
  • Loomis, Sayles & Company sold 319,666 Astrana Health shares in Q1 2025, an estimated $10.1M.
  • Loomis, Sayles & Company first reported a position in Astrana Health in Q3 2024 and held it in 2 quarters.
  • Loomis, Sayles & Company's Astrana Health position peaked at $30.3M in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on Loomis, Sayles & Company's 13F filing for Q1 2025, filed 14 May 2025.